F9L-17926-40605
2 vaccinations
1 coded response
5 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 606 / IL
- Registered
- 2022-01-01
- Relationship
- Adult relative or friend
- Guardian
- 3LW-15365-13770
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Dose 1 — Janssen/Johnson & Johnson
-
2021-12-01
Dose 2 — Pfizer-BioNTech
-
2022-01-01
Registered in v-safe
- 2022-01-01
-
2022-01-05
Survey response — day 35, dose 2, dependentMedDRA: Fatigue — Feeling: GoodFree text: Extremely tiredMedDRA releases: 2024-11 · check-in free text available
- 2022-03-04
- 2022-06-01
- 2022-12-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Janssen/Johnson & Johnson | No |
| 2 | 2021-12-01 | Pfizer-BioNTech | No |
Free text
Release 10 — day 35, dose 2, dependent
Symptoms: Extremely tired
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release